Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06491537 · ClinicalTrials.gov registry record · NA

Time-restricted Eating for Postpartum Weight Loss

A NA study of Overweight and Obesity and Postpartum Weight Retention, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06491537 is a NA study of Overweight and Obesity and Postpartum Weight Retention that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 60 participants, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06491537, a NA study of Overweight and Obesity and Postpartum Weight Retention, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This study is being done to assess the feasibility and acceptability of a time-restricted eating intervention among postpartum women with overweight/obesity.

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL Early Time-Restricted Eating (eTRE)

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-05-22
Est. Completion 2029-02-01
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT06491537

The ClinicalTrials.gov registry entry for NCT06491537 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (74% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Overweight and Obesity appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.

NCT06491537 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT06491537 about?

NCT06491537 is a clinical study titled "Time-restricted Eating for Postpartum Weight Loss". This study is being done to assess the feasibility and acceptability of a time-restricted eating intervention among postpartum women with overweight/obesity.

What is the current status of trial NCT06491537?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-05-22. Estimated completion is 2029-02-01.

What conditions does trial NCT06491537 study?

This clinical trial studies the following conditions: Overweight and Obesity, Postpartum Weight Retention.

What interventions are being tested in trial NCT06491537?

The interventions under investigation include: Control (BEHAVIORAL), Early Time-Restricted Eating (eTRE) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06491537?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06491537 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overweight and Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.